Hakan Kardes Sells 35,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Hakan Kardes sold 35,000 shares of the firm's stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $12.80, for a total value of $448,000.00. Following the completion of the sale, the insider now owns 320,444 shares in the company, valued at approximately $4,101,683.20. This represents a 9.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Hakan Kardes also recently made the following trade(s):

• On Monday, November 4th, Hakan Kardes sold 20,500 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.06, for a total value of $267,730.00.
• On Friday, November 1st, Hakan Kardes sold 4,500 shares of Alignment Healthcare stock. The shares were sold at an average price of $12.98, for a total transaction of $58,410.00.
• On Thursday, September 12th, Hakan Kardes sold 25,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $11.48, for a total transaction of $287,000.00.

Alignment Healthcare Trading Down 1.7 %

Shares of Alignment Healthcare stock traded down $0.22 on Friday, reaching $12.61. 715,141 shares of the company were exchanged, compared to its average volume of 1,146,775. Alignment Healthcare, Inc. has a fifty-two week low of $4.46 and a fifty-two week high of $14.25. The firm has a market capitalization of $2.42 billion, a price-to-earnings ratio of -16.38 and a beta of 1.45. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The stock has a fifty day moving average price of $11.81 and a 200-day moving average price of $9.75.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, meeting analysts' consensus estimates of ($0.14). The company had revenue of $692.43 million during the quarter, compared to analyst estimates of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The business's quarterly revenue was up 51.6% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.19) earnings per share. On average, analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Ratings Changes

ALHC has been the subject of a number of research analyst reports. Robert W. Baird upped their price target on shares of Alignment Healthcare from $10.00 to $11.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 14th. Piper Sandler restated an "overweight" rating and issued a $10.00 target price (up from $8.00) on shares of Alignment Healthcare in a research report on Tuesday, August 6th. Barclays lifted their price target on Alignment Healthcare from $7.00 to $8.00 and gave the company an "underweight" rating in a research report on Wednesday, October 30th. UBS Group boosted their price objective on Alignment Healthcare from $9.00 to $12.00 and gave the stock a "neutral" rating in a research note on Wednesday, October 30th. Finally, TD Cowen raised their target price on Alignment Healthcare from $8.00 to $10.00 and gave the company a "buy" rating in a research note on Tuesday, August 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, six have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $10.33.

Hedge Funds Weigh In On Alignment Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Virtu Financial LLC acquired a new position in shares of Alignment Healthcare in the 1st quarter valued at about $57,000. nVerses Capital LLC acquired a new stake in shares of Alignment Healthcare during the third quarter worth approximately $95,000. Principal Financial Group Inc. grew its position in Alignment Healthcare by 18.1% during the second quarter. Principal Financial Group Inc. now owns 13,521 shares of the company's stock valued at $106,000 after purchasing an additional 2,077 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Alignment Healthcare in the 3rd quarter worth approximately $131,000. Finally, Creative Planning lifted its position in Alignment Healthcare by 20.0% in the 3rd quarter. Creative Planning now owns 12,442 shares of the company's stock worth $147,000 after buying an additional 2,072 shares in the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.